Slingshot members are tracking this corporate initiative:
Novartis (NVS) Out-Licenses U.S Rights to Three Treatments for Chronic Obstructive Pulmonary Disease (COPD) to Sunovion Pharmaceuticals
Slingshot Insights Explained
Strategic Initiative Date
Announcement Date: Dec 21, 2016 Projected Implementation: Q1, 2017 Relevance Tracked Until: Q1, 2018
Don’t see a project related to the strategic initiative you care about?
Related Keywords U.s Rights, Three Treatments, Chronic Obstructive Pulmonary Disease, Copd, Utibron Neohaler, Seebri Neohaler, Arcapta Neohaler